Serum NGAL, KIM-1, IL-18, L-FABP: new biomarkers in the diagnostics of acute kidney injury (AKI) following invasive cardiology procedures.

Magdalena ZdziechowskaAnna Gluba-BrzózkaAdam R PoliwczakBeata FranczykMichał KidawaMarzenna ZielinskaJacek Rysz

Published in: International urology and nephrology (2020)

Obtained results do not allow for the indication of efficient AKI biomarkers. Their further validation in large studies of CI-AKI patients is required.

Keyphrases

acute kidney injury
cardiac surgery
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
binding protein